Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaofeng Yu

Showing results (151-160 of 231) with videos related to

Pageof 24
Sort By:
RSC Advances|April 28, 2022
<i>In situ</i> formation of 2-thiobarbituric acid incorporated g-C<sub>3</sub>N<sub>4</sub> for enhanced visible-light-driven photocatalytic performanceTingting Chen, Shan Hu, Quanfeng Xing, et al.
Journal of Food Science|October 19, 2020
Ginsenoside Rb2 alleviates myocardial ischemia/reperfusion injury in rats through SIRT1 activationYan Xue, Wenwen Fu, Yanzhe Liu, et al.
Experimental and Therapeutic Medicine|June 16, 2020
Rosuvastatin protects against endothelial cell apoptosis <i>in vitro</i> and alleviates atherosclerosis in ApoE<sup>-/-</sup> mice by suppressing endoplasmic reticulum stressJianan Geng, Huali Xu, Wenwen Fu, et al.
Journal of Food Science|June 19, 2021
Protective effects of ginsenoside Rc against acute cold exposure-induced myocardial injury in ratsYan Xue, Xiaofeng Yu, Xiuhang Zhang, et al.
Protein Expression and Purification|January 1, 2019
Transcriptomic analysis of key genes involved in chlorogenic acid biosynthetic pathway and characterization of MaHCT from Morus alba LLi Zhao, Dujun Wang, Jia Liu, et al.
Breast Cancer Research : BCR|July 1, 2026
Exploring LTB-mediated T cell differentiation as a prognostic marker in triple-negative breast cancerXuekai Wang, Yingxiao Ni, Yang Shi, et al.
Frontiers in Pharmacology|March 8, 2021
Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway InactivationTianyu Zhai, Xiaoyu Zhang, Zhenyu Hei, et al.
Frontiers in Pharmacology|November 8, 2021
Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis <i>via</i> PI3K/AKT Signaling Pathway InactivationTianyu Zhai, Xiaoyu Zhang, Zhenyu Hei, et al.
Journal of Molecular Recognition : JMR|January 21, 2015
Dynamics of CYP51: implications for function and inhibitor designXiaofeng Yu, Vlad Cojocaru, Ghulam Mustafa, et al.
Experimental Cell Research|May 27, 2021
TWIST2 inhibits EMT and induces oxidative stress in lung cancer cells by regulating the FGF21-mediated AMPK/mTOR pathwayYingjian Song, Wei Zhang, Jiuxu Zhang, et al.
Pageof 24

Showing results (151-160 of 231) with videos related to

Sort By:
Pageof 24
RSC Advances|April 28, 2022
<i>In situ</i> formation of 2-thiobarbituric acid incorporated g-C<sub>3</sub>N<sub>4</sub> for enhanced visible-light-driven photocatalytic performanceTingting Chen, Shan Hu, Quanfeng Xing, et al.
Journal of Food Science|October 19, 2020
Ginsenoside Rb2 alleviates myocardial ischemia/reperfusion injury in rats through SIRT1 activationYan Xue, Wenwen Fu, Yanzhe Liu, et al.
Experimental and Therapeutic Medicine|June 16, 2020
Rosuvastatin protects against endothelial cell apoptosis <i>in vitro</i> and alleviates atherosclerosis in ApoE<sup>-/-</sup> mice by suppressing endoplasmic reticulum stressJianan Geng, Huali Xu, Wenwen Fu, et al.
Journal of Food Science|June 19, 2021
Protective effects of ginsenoside Rc against acute cold exposure-induced myocardial injury in ratsYan Xue, Xiaofeng Yu, Xiuhang Zhang, et al.
Protein Expression and Purification|January 1, 2019
Transcriptomic analysis of key genes involved in chlorogenic acid biosynthetic pathway and characterization of MaHCT from Morus alba LLi Zhao, Dujun Wang, Jia Liu, et al.
Breast Cancer Research : BCR|July 1, 2026
Exploring LTB-mediated T cell differentiation as a prognostic marker in triple-negative breast cancerXuekai Wang, Yingxiao Ni, Yang Shi, et al.
Frontiers in Pharmacology|March 8, 2021
Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway InactivationTianyu Zhai, Xiaoyu Zhang, Zhenyu Hei, et al.
Frontiers in Pharmacology|November 8, 2021
Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis <i>via</i> PI3K/AKT Signaling Pathway InactivationTianyu Zhai, Xiaoyu Zhang, Zhenyu Hei, et al.
Journal of Molecular Recognition : JMR|January 21, 2015
Dynamics of CYP51: implications for function and inhibitor designXiaofeng Yu, Vlad Cojocaru, Ghulam Mustafa, et al.
Experimental Cell Research|May 27, 2021
TWIST2 inhibits EMT and induces oxidative stress in lung cancer cells by regulating the FGF21-mediated AMPK/mTOR pathwayYingjian Song, Wei Zhang, Jiuxu Zhang, et al.
Pageof 24